Literature DB >> 12828155

Maternal respiratory syncytial virus antibody titers: season and children matter.

Nicole Le Saux1, Isabelle Gaboury, Noni MacDonald.   

Abstract

The seasonal variation in concentrations of maternal serum antibodies to respiratory syncytial virus fusion protein was investigated with the use of 761 maternal sera at delivery of term infants during a 12-month period. Mean antibody titers were significantly higher between April and September and significantly higher in women who already had children at home.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12828155

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  5 in total

1.  Climatic factors and lower respiratory tract infection due to respiratory syncytial virus in hospitalised infants in northern Spain.

Authors:  Santiago Lapeña; Mariá Belén Robles; Leticia Castañón; Juan Pablo Martínez; Sofiá Reguero; María Paz Alonso; Isabel Fernández
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 2.  Respiratory Syncytial Virus: The Influence of Serotype and Genotype Variability on Clinical Course of Infection.

Authors:  Silvia Vandini; Carlotta Biagi; Marcello Lanari
Journal:  Int J Mol Sci       Date:  2017-08-06       Impact factor: 5.923

Review 3.  Reducing the impact of viral respiratory infections in children.

Authors:  H Cody Meissner
Journal:  Pediatr Clin North Am       Date:  2005-06       Impact factor: 3.278

4.  Vaccination against RSV: is maternal vaccination a good alternative to other approaches?

Authors:  Patricia Kaaijk; Willem Luytjes; Nynke Y Rots
Journal:  Hum Vaccin Immunother       Date:  2013-02-26       Impact factor: 3.452

5.  Evaluation of respiratory syncytial virus IgG antibody dynamics in mother-infant pairs cohort.

Authors:  Mehmet Yildiz; Manolya Kara; Murat Sutcu; Sevim Mese; Mehmet Emin Demircili; Tugba Sarac Sivrikoz; Selda Hancerli Torun; Ali Agacfidan; Asuman Coban; Emin Unuvar; Ayper Somer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-02-14       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.